HEADER VIRAL PROTEIN 12-JUN-08 2VVW TITLE STRUCTURE OF VACCINIA VIRUS PROTEIN A52 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN A52; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 37-190; COMPND 5 SYNONYM: A52; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: VACCINIA VIRUS; SOURCE 3 ORGANISM_TAXID: 10245; SOURCE 4 STRAIN: WESTERN RESERVE; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: ROSETTA(DE3) PLYSS; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: POPINF KEYWDS IRAK2, TRAF6, BCL-2 FAMILY, VACCINIA VIRUS, IMMUNOMODULATOR, NF-KB KEYWDS 2 ACTIVATION, VIRAL PROTEIN, HOST-VIRUS INTERACTION EXPDTA X-RAY DIFFRACTION AUTHOR S.C.GRAHAM,M.W.BAHAR,S.COORAY,R.A.-J.CHEN,D.M.WHALEN,N.G.A.ABRESCIA, AUTHOR 2 D.ALDERTON,R.J.OWENS,D.I.STUART,G.L.SMITH,J.M.GRIMES REVDAT 4 08-MAY-24 2VVW 1 REMARK REVDAT 3 08-MAY-19 2VVW 1 REMARK REVDAT 2 24-FEB-09 2VVW 1 VERSN REVDAT 1 26-AUG-08 2VVW 0 JRNL AUTH S.C.GRAHAM,M.W.BAHAR,S.COORAY,R.A.-J.CHEN,D.M.WHALEN, JRNL AUTH 2 N.G.A.ABRESCIA,D.ALDERTON,R.J.OWENS,D.I.STUART,G.L.SMITH, JRNL AUTH 3 J.M.GRIMES JRNL TITL VACCINIA VIRUS PROTEINS A52 AND B14 SHARE A BCL-2-LIKE FOLD JRNL TITL 2 BUT HAVE EVOLVED TO INHIBIT NF-KAPPAB RATHER THAN APOPTOSIS JRNL REF PLOS PATHOG. V. 4 E128 2008 JRNL REFN ISSN 1553-7366 JRNL PMID 18704168 JRNL DOI 10.1371/JOURNAL.PPAT.1000128 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.77 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 29385 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.179 REMARK 3 R VALUE (WORKING SET) : 0.177 REMARK 3 FREE R VALUE : 0.215 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1571 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.95 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2161 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2520 REMARK 3 BIN FREE R VALUE SET COUNT : 86 REMARK 3 BIN FREE R VALUE : 0.2980 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2508 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 207 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 24.16 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.03 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.44000 REMARK 3 B22 (A**2) : -0.75000 REMARK 3 B33 (A**2) : -2.17000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.84000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.132 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.127 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.099 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.892 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.964 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.948 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2591 ; 0.010 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1822 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3484 ; 1.107 ; 1.975 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4435 ; 0.834 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 306 ; 4.900 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 136 ;35.197 ;24.485 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 521 ;13.421 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 18 ;12.508 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 381 ; 0.068 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2822 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 544 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 558 ; 0.209 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 1831 ; 0.173 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1279 ; 0.184 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 1321 ; 0.082 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 155 ; 0.151 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 2 ; 0.211 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 19 ; 0.345 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 7 ; 0.224 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1644 ; 1.371 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2430 ; 1.873 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1226 ; 2.832 ; 4.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1050 ; 4.123 ; 6.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 40 A 190 REMARK 3 ORIGIN FOR THE GROUP (A): 35.8840 -13.5990 12.4510 REMARK 3 T TENSOR REMARK 3 T11: -0.1513 T22: -0.1196 REMARK 3 T33: -0.1119 T12: 0.0105 REMARK 3 T13: 0.0103 T23: 0.0010 REMARK 3 L TENSOR REMARK 3 L11: 0.9188 L22: 1.8621 REMARK 3 L33: 3.4055 L12: 0.2125 REMARK 3 L13: 0.2802 L23: 0.2958 REMARK 3 S TENSOR REMARK 3 S11: 0.0301 S12: -0.0406 S13: -0.0349 REMARK 3 S21: 0.0969 S22: -0.0032 S23: -0.0980 REMARK 3 S31: 0.2742 S32: 0.0004 S33: -0.0269 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 40 B 190 REMARK 3 ORIGIN FOR THE GROUP (A): 36.7870 14.4260 18.8660 REMARK 3 T TENSOR REMARK 3 T11: -0.1367 T22: -0.1165 REMARK 3 T33: -0.1294 T12: -0.0314 REMARK 3 T13: 0.0269 T23: -0.0116 REMARK 3 L TENSOR REMARK 3 L11: 1.6328 L22: 2.0637 REMARK 3 L33: 2.8993 L12: -0.5654 REMARK 3 L13: 1.0628 L23: 0.1364 REMARK 3 S TENSOR REMARK 3 S11: -0.1016 S12: -0.0630 S13: 0.0954 REMARK 3 S21: 0.0828 S22: 0.0736 S23: -0.0976 REMARK 3 S31: -0.1727 S32: 0.0253 S33: 0.0280 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. B VALUES INCLUDE TLS CONTRIBUTIONS. REMARK 4 REMARK 4 2VVW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-JUN-08. REMARK 100 THE DEPOSITION ID IS D_1290036545. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-AUG-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9395 REMARK 200 MONOCHROMATOR : SILICON (111) CRYSTAL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30971 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 4.100 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.93 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 4.10 REMARK 200 R MERGE FOR SHELL (I) : 0.71000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: AUTOSHARP REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.84 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.55 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: HANGING DROPS CONTAINING 1 UL PROTEIN REMARK 280 (5.3 MG/ML IN 20 MM TRIS, 200 MM NACL, PH 7.5) AND 1 UL REMARK 280 RESERVOIR SOLUTION (0.2 M TRISODIUM CITRATE, 18% (W/V) PEG 3350) REMARK 280 WERE EQUILIBRATED AGAINST 500 UL RESERVOIRS AT 21 C. CRYSTALS REMARK 280 WERE CRYOPROTECTED IN RESERVOIR SOLUTION SUPPLEMENTED WITH 20% REMARK 280 (V/V) GLYCEROL., VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 29.57200 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 1550 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18220 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.4 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 36 REMARK 465 THR A 37 REMARK 465 ASP A 38 REMARK 465 VAL A 39 REMARK 465 SER A 190 REMARK 465 LYS A 191 REMARK 465 HIS A 192 REMARK 465 HIS A 193 REMARK 465 HIS A 194 REMARK 465 HIS A 195 REMARK 465 HIS A 196 REMARK 465 HIS A 197 REMARK 465 MET B 36 REMARK 465 THR B 37 REMARK 465 ASP B 38 REMARK 465 VAL B 39 REMARK 465 SER B 190 REMARK 465 LYS B 191 REMARK 465 HIS B 192 REMARK 465 HIS B 193 REMARK 465 HIS B 194 REMARK 465 HIS B 195 REMARK 465 HIS B 196 REMARK 465 HIS B 197 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 73 CD NE CZ NH1 NH2 REMARK 470 LYS A 75 CG CD CE NZ REMARK 470 GLU A 92 CG CD OE1 OE2 REMARK 470 TYR A 186 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS B 75 CE NZ REMARK 470 ARG B 78 NE CZ NH1 NH2 REMARK 470 LYS B 128 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG B 73 44.04 -86.36 REMARK 500 REMARK 500 REMARK: NULL REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR PROVIDED. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2VVX RELATED DB: PDB REMARK 900 STRUCTURE OF VACCINIA VIRUS PROTEIN A52 REMARK 900 RELATED ID: 2VVY RELATED DB: PDB REMARK 900 STRUCTURE OF VACCINIA VIRUS PROTEIN B14 REMARK 900 RELATED ID: 2I39 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF VACCINIA VIRUS N1L PROTEIN REMARK 900 RELATED ID: 2UXE RELATED DB: PDB REMARK 900 THE STRUCTURE OF VACCINIA VIRUS N1 REMARK 900 RELATED ID: 2JBX RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE MYXOMA VIRUS ANTI- APOPTOTIC PROTEIN M11L REMARK 900 RELATED ID: 2JBY RELATED DB: PDB REMARK 900 A VIRAL PROTEIN UNEXPECTEDLY MIMICS THE STRUCTURE AND FUNCTION OF REMARK 900 PRO-SURVIVAL BCL-2 REMARK 999 REMARK 999 SEQUENCE REMARK 999 RESIDUES 1-36 ARE REMOVED, AN N-TERMINAL START CODON IS REMARK 999 ADDED AND A C-TERMINAL LYS-HIS6 PURIFICATION TAG IS ADDED. DBREF 2VVW A 36 36 PDB 2VVW 2VVW 36 36 DBREF 2VVW A 37 190 UNP Q01220 VA52_VACCV 37 190 DBREF 2VVW A 191 197 PDB 2VVW 2VVW 191 197 DBREF 2VVW B 36 36 PDB 2VVW 2VVW 36 36 DBREF 2VVW B 37 190 UNP Q01220 VA52_VACCV 37 190 DBREF 2VVW B 191 197 PDB 2VVW 2VVW 191 197 SEQRES 1 A 162 MET THR ASP VAL ILE LYS PRO ASP TYR LEU GLU TYR ASP SEQRES 2 A 162 ASP LEU LEU ASP ARG ASP GLU MET PHE THR ILE LEU GLU SEQRES 3 A 162 GLU TYR PHE MET TYR ARG GLY LEU LEU GLY LEU ARG ILE SEQRES 4 A 162 LYS TYR GLY ARG LEU PHE ASN GLU ILE LYS LYS PHE ASP SEQRES 5 A 162 ASN ASP ALA GLU GLU GLN PHE GLY THR ILE GLU GLU LEU SEQRES 6 A 162 LYS GLN LYS LEU ARG LEU ASN SER GLU GLU GLY ALA ASP SEQRES 7 A 162 ASN PHE ILE ASP TYR ILE LYS VAL GLN LYS GLN ASP ILE SEQRES 8 A 162 VAL LYS LEU THR VAL TYR ASP CYS ILE SER MET ILE GLY SEQRES 9 A 162 LEU CYS ALA CYS VAL VAL ASP VAL TRP ARG ASN GLU LYS SEQRES 10 A 162 LEU PHE SER ARG TRP LYS TYR CYS LEU ARG ALA ILE LYS SEQRES 11 A 162 LEU PHE ILE ASN ASP HIS MET LEU ASP LYS ILE LYS SER SEQRES 12 A 162 ILE LEU GLN ASN ARG LEU VAL TYR VAL GLU MET SER LYS SEQRES 13 A 162 HIS HIS HIS HIS HIS HIS SEQRES 1 B 162 MET THR ASP VAL ILE LYS PRO ASP TYR LEU GLU TYR ASP SEQRES 2 B 162 ASP LEU LEU ASP ARG ASP GLU MET PHE THR ILE LEU GLU SEQRES 3 B 162 GLU TYR PHE MET TYR ARG GLY LEU LEU GLY LEU ARG ILE SEQRES 4 B 162 LYS TYR GLY ARG LEU PHE ASN GLU ILE LYS LYS PHE ASP SEQRES 5 B 162 ASN ASP ALA GLU GLU GLN PHE GLY THR ILE GLU GLU LEU SEQRES 6 B 162 LYS GLN LYS LEU ARG LEU ASN SER GLU GLU GLY ALA ASP SEQRES 7 B 162 ASN PHE ILE ASP TYR ILE LYS VAL GLN LYS GLN ASP ILE SEQRES 8 B 162 VAL LYS LEU THR VAL TYR ASP CYS ILE SER MET ILE GLY SEQRES 9 B 162 LEU CYS ALA CYS VAL VAL ASP VAL TRP ARG ASN GLU LYS SEQRES 10 B 162 LEU PHE SER ARG TRP LYS TYR CYS LEU ARG ALA ILE LYS SEQRES 11 B 162 LEU PHE ILE ASN ASP HIS MET LEU ASP LYS ILE LYS SER SEQRES 12 B 162 ILE LEU GLN ASN ARG LEU VAL TYR VAL GLU MET SER LYS SEQRES 13 B 162 HIS HIS HIS HIS HIS HIS FORMUL 3 HOH *207(H2 O) HELIX 1 1 MET A 56 LEU A 70 1 15 HELIX 2 2 ARG A 78 PHE A 94 1 17 HELIX 3 3 ILE A 97 LYS A 103 1 7 HELIX 4 4 GLY A 111 ASP A 125 1 15 HELIX 5 5 VAL A 131 ASN A 150 1 20 HELIX 6 7 PHE A 154 ARG A 156 5 3 HELIX 7 8 TRP A 157 PHE A 167 1 11 HELIX 8 9 ASP A 170 VAL A 187 1 18 HELIX 9 10 MET B 56 LEU B 70 1 15 HELIX 10 11 ARG B 78 PHE B 94 1 17 HELIX 11 12 ILE B 97 LYS B 103 1 7 HELIX 12 13 GLY B 111 ASP B 125 1 15 HELIX 13 14 VAL B 131 ASN B 150 1 20 HELIX 14 15 PHE B 154 ARG B 156 5 3 HELIX 15 16 TRP B 157 PHE B 167 1 11 HELIX 16 17 ASP B 170 VAL B 187 1 18 CRYST1 46.208 59.144 75.719 90.00 106.58 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021641 0.000000 0.006443 0.00000 SCALE2 0.000000 0.016908 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013780 0.00000